Unlock instant, AI-driven research and patent intelligence for your innovation.

Inhibition of target crtac1 in lung adenocarcinoma and its application

1. The technology of CRTAC1 and lung adenocarcinoma is applied in the direction of microbial measurement/testing, medical preparations containing active ingredients, instruments, etc., to achieve the effect of auxiliary diagnosis of lung adenocarcinoma

Active Publication Date: 2021-08-24
WENZHOU MEDICAL UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current research on the CRTAC1 gene mainly focuses on genomics analysis, but in terms of basic medicine, there are only a few reports on cataract treatment and the pathogenesis of neurofibromatosis type 1 (NF1)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhibition of target crtac1 in lung adenocarcinoma and its application
  • Inhibition of target crtac1 in lung adenocarcinoma and its application
  • Inhibition of target crtac1 in lung adenocarcinoma and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Example 1. The expression of CRTAC1 is consistently down-regulated in lung adenocarcinoma tissues and cell lines

[0065] 1) Use GraphPad Prism software to analyze the expression of CRTAC1 mRNA in 58 pairs of lung adenocarcinoma patients in the TCGA database by t-test results. Pfigure 1 A).

[0066] 2) Tissue samples

[0067] The clinical samples of lung adenocarcinoma used in the present invention were provided by a cooperative hospital, and the tissue was diagnosed as lung adenocarcinoma by a pathologist. When the specimen was collected, a position about 3 cm around the lung adenocarcinoma tissue was selected as the paracancerous tissue control, and a part of the tissue was fixed with 4% PFA, and the rest was frozen at -80 degrees for later use. All patients have detailed information such as name and pathological information. The experimental operation was approved by ethical review.

[0068] 3) Tissue / cell total RNA extraction

[0069] 1. Take out the collected l...

Embodiment 2

[0098] Kaplan-Meier survival analysis was performed on the survival information of CRTAC1 in 401 patients with lung adenocarcinoma in the TCGA database using GraphPad Prism software. The results of the overall survival rate of lung adenocarcinoma samples showed P figure 2 A). That is, the expression of CRTAC1 was significantly positively correlated with the survival time of patients with lung adenocarcinoma ( figure 2 A).

Embodiment 3

[0099] Example 3. Overexpression of CRTAC1 significantly inhibits the proliferation ability of lung adenocarcinoma cells

[0100] 1) Select H1299 and A549 cells as research objects, infect GFP-CRTAC1 plasmid and GFP empty plasmid virus supernatant in H1299 and A549 cells, and use Puromycin drug screening to establish stable cell lines H1299 (CRTAC1), A549 (CRTAC1) and The control cell lines H1299 (Vector) and A549 (Vector). Western Blot was used to detect the overexpression effect, and β-Actin was used as an internal reference, such as image 3 A and 3D are shown.

[0101] 2) The soft agar colony formation experiment was used. At room temperature, a medium was prepared in a clean bench, and 12.6ml (1.8ml×7) was preheated at 45-46°C for more than 10min. Microwave heating and boiling agar for 3 times, after cooling to 45-46°C, take 8.4ml (1.2ml×7) of agar and mix quickly in a medium preheating tube, absorb 3ml / well and spread the next layer of agar glue, and let it solidify natu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of CRTAC1 as a target in the preparation of medicines for diagnosing and treating lung adenocarcinoma, which can be used as a target for growth, proliferation, invasion and migration of lung adenocarcinoma cells. The present invention has the following functions: overexpression of CRTAC1 inhibits the proliferation of lung adenocarcinoma cells; overexpression of CRTAC1 inhibits subcutaneous tumor formation in nude mice; overexpression of CRTAC1 inhibits the migration and invasion of lung adenocarcinoma cells; overexpression of CRTAC1 inhibits the formation of lung metastases in nude mice .

Description

technical field [0001] The invention belongs to the field of biotechnology, and specifically relates to a new target for the study of growth, proliferation and metastasis of lung adenocarcinoma cells and its application, detecting the mRNA or protein expression level of CRTAC1, which can further be used as a diagnostic and prognostic marker for lung adenocarcinoma, and expectations It has become a new target for the treatment of lung adenocarcinoma. Background technique [0002] Lung cancer is one of the malignant tumors with the fastest-growing morbidity and mortality, and the greatest threat to the health and life of the population. According to the latest survey results of CONCORD-3 (the third round of global cancer survival analysis) published by "The Lancet": The five-year survival rate of lung cancer patients in most countries is between 10-19%, and in China it is 19.4-20.2%. According to the latest statistics from the Cancer Center of my country, lung cancer ranks fi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886G01N33/574A61K45/00A61P35/00
CPCA61K45/00A61P35/00C12Q1/6886C12Q2600/158G01N33/57423G01N33/57484
Inventor 黄海山常园园李海英金红蕾
Owner WENZHOU MEDICAL UNIV